Close
FINDING CURES TOGETHER<sup>SM</sup>
Frederick R. Appelbaum, MD

Frederick R. Appelbaum, MD
Director, Clinical Research DivisionFred Hutchinson Cancer Research CenterHead, Division of OncologyUniversity of Washington School of MedicinePresident, Seattle Cancer Care Alliance
​Seattle, Washington

Dr. Frederick R. Appelbaum is director, Clinical Research Division at the Fred Hutchinson Cancer Research Center, head, Division of Oncology at the University of Washington School of Medicine, and president, Seattle Cancer Care Alliance. Dr. Appelbaum graduated from Dartmouth College and Tufts University School of Medicine. He completed internal medicine training at the University of Michigan and medical oncology fellowship training at the National Cancer Institute. He remained at the National Cancer Institute as an investigator until 1978, when he moved to Seattle to join the faculty of the Fred Hutchinson Cancer Research Center and the University of Washington.

Dr. Appelbaum’s research focuses on the biology and treatment of acute myeloid leukemia, with a particular emphasis on hematopoietic cell transplantation. He was the lead author of the first paper describing the successful use of autologous marrow transplantation.

Dr. Appelbaum is a past chair of the Board of Scientific Advisors of the National Cancer Institute. He has been a board member of a number of scientific societies, including the American Society of Hematology, the American Society of Clinical Oncology and the American Society for Blood and Marrow Transplantation. He is a member of the National Cancer Policy Forum and serves on the NCI Steering Committees for both pediatric and adult leukemia. He heads the Clinical Transplant Research Program at the Fred Hutchinson Cancer Research Center and chairs the Leukemia Committee of the Southwest Oncology Group.